Katharine Gammon is an award-winning independent science journalist based in Santa Monica, California. Her work has appeared in The New York Times, The Atlantic, WIRED, The Guardian, Undark, Popular Science, MIT Technology Review, Nature, Hakai and beyond.
Katharine Gammon
From this contributor
Spotted around the web: Mapping histones; COVID-19 births; acetaminophen lawsuits
Here is a roundup of news and research for the week of 31 October.
Spotted around the web: Mapping histones; COVID-19 births; acetaminophen lawsuits
By
Jill Adams, Katharine Gammon, Peter Hess, Nicholette Zeliadt
4 November 2022 | 3 min read
A mix of common and rare variants shapes autism inheritance patterns
The study also reveals a link between language development and common variants.
A mix of common and rare variants shapes autism inheritance patterns
By
Katharine Gammon
4 November 2022 | 3 min read
Zebrafish point to new gene involved in brain overgrowth, autism
The gene, YTHDF2, has not previously been linked to autism.
Zebrafish point to new gene involved in brain overgrowth, autism
By
Katharine Gammon
1 November 2022 | 3 min read
Lags in genetic testing, variant reporting hinder autism research
Few autistic people undergo the recommended genetic testing for their condition, and test results often do not make their way into public databases, where researchers and clinicians can learn from them.
Lags in genetic testing, variant reporting hinder autism research
By
Katharine Gammon
28 October 2022 | 4 min read
Explore more from The Transmitter
When autistic kids grow up, Chapter 1: Those people
What leads an autism researcher to publish an intentionally inflammatory paper accusing the NIH of discrimination?
When autistic kids grow up, Chapter 1: Those people
What leads an autism researcher to publish an intentionally inflammatory paper accusing the NIH of discrimination?
By
Brady Huggett
4 June 2026 | 24 min listen
Supported by a $40 million NIH grant, Yale brain shuttle technology raises questions
Yale University claims its STEP platform might be able to deliver gene-editing tools into the brain via multiple routes. Researchers are eager to see more.
Supported by a $40 million NIH grant, Yale brain shuttle technology raises questions
Yale University claims its STEP platform might be able to deliver gene-editing tools into the brain via multiple routes. Researchers are eager to see more.
By
Natalia Mesa
3 June 2026 | 11 min read
What counts as a ‘naturalistic’ behavior?
Nedah Nemati explains how neuroscience methods and the lived experience of the scientists themselves shape how we define the behaviors we seek to explain.
What counts as a ‘naturalistic’ behavior?
Nedah Nemati explains how neuroscience methods and the lived experience of the scientists themselves shape how we define the behaviors we seek to explain.
By
Paul Middlebrooks
3 June 2026 | 1 min read